CEO Leon Moulder Fuels Hope in Zenas Biopharma Stock Slump with Steady 100k‑Share Buying Spree
CEO Leon Moulder’s 100k‑share buying spree shows insider confidence in Zenas Biopharma’s immunology pipeline, hinting at a rebound amid volatile stock swings.
4 minutes to read